coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Rural Alliance PCN, Cheshire West and Chester (LAD) · Health Inequalities Profile

    PCN U66020 · NHS Cheshire and Merseyside Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    42,430

    Registered population

    54.1% aged 18–64

    28.7%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.0%

    Ethnic minority (non-White)

    1.0% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    7,687

    Hypertension register

    +8.41% in 3 yrs · England +5.60%

    296

    SMI register

    7.9% of Cheshire West and Chester (LAD)'s

    670

    COPD register

    Reviews +2.78% in 3 yrs

    Forecast to 2030

    9,413

    Hypertension patients, 2030

    +1,726 on today

    70.9%

    QRISK ≥20% on statins, 2030

    +3.95pp over 3 yrs

    7.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -7.1%
    Under-80 blood pressure control is slipping.

    Control fell 7.1% over three years (England +3.2%) to 67.5%, while QRISK ≥ 20% lipid therapy is 62.2% against 63.6% in England.

    -5.2%
    Asthma reviews and youth smoke checks lag.

    Annual asthma reviews fell 5.2% (England +4.4%) to 66.0%, leaving about 960 patients unreviewed, while youth second-hand smoking recording is 69.9% (England 78.8%).

    +12.4%
    Non-frail diabetes glycaemic control improved strongly.

    HbA1c control without frailty rose +12.4% over three years (England +4.4%) to 61.8% (England 57.4%), alongside 83.6% control in frail diabetes (England 81.9%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ comprise 28.7% of the list, 10.8 percentage points above England

    Rural Alliance PCN serves 42,430 registered patients across six practices. The population is older than comparators: 28.7% (12,185 patients) are aged 65+, compared with 20.3% in Cheshire West and Chester, 19.0% in the ICB, and 17.9% in England. Patients aged 18-64 represent 54.1% and those aged 0-17 represent 17.2%. Area Census estimates show 97.0% White ethnicity against 95.3% in Cheshire West and Chester, 93.0% in the ICB, and 81.1% in England. Practice lists sum to 51,036, indicating unresolved denominator alignment, and Census ethnicity reflects catchment residents rather than GP registers.

    Age profile

    0–1717.2%
    18–6454.1%
    65+28.7%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White97.0%
    Mixed1.3%
    Asian1.0%
    Black0.4%
    Other0.3%

    Older people · falls rows are Cheshire West and Chester (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Cheshire West and Chester LA)2,1092,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)61.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Cheshire West and Chester LA)8931,0219552024/25
    Falls deaths, all ages, per 100,000 (Cheshire West and Chester LA)14.918.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 7.5, with 0.0% of registered patients in Core20 areas

    The PCN sits at an average IMD decile of 7.5, reflecting lower deprivation than Cheshire West and Chester (6.3), the ICB (5.2), and England (5.5). Across all six practices, 0.0% of registered patients reside in Core20 areas (an estimated 0 patients), compared to 15.7% in Cheshire West and Chester, 31.9% in the ICB, and 21.0% in England. Practice average deciles include 6.5 at Laurel Bank Surgery and 7.8 at Tarporley Health Centre.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Bunbury Medical0.0% · 0 patients
    Tarporley0.0% · 0 patients
    Drs Adey And0.0% · 0 patients
    Laurel Bank0.0% · 0 patients
    Kelsall0.0% · 0 patients
    Village Surgeries0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    296

    SMI register

    0.70% recorded prevalence

    146

    Learning disability register

    0.35% recorded prevalence

    8

    Care homes, 316 beds

    In the PCN catchment

    9.6%

    Provide unpaid care

    Cheshire West and Chester (LAD), Census 2021

    Recorded learning disability prevalence is 0.3% (146 patients) against 0.5% in Cheshire West and Chester, 0.6% in the ICB, and 0.6% in England; severe mental illness is 0.7% (296 patients) against 1.0%, 1.1%, and 1.0%. The catchment contains 8 care homes with 316 beds, though resident registrations are unconfirmed.

    Severe mental illness: physical health checks

    Recorded SMI blood pressure checks reach 87.3% (England 83.4%) and BMI checks reach 87.7% (England 82.1%). Smoking cessation support fell 3.2 pp from 2023 to 2025 (England +0.1 pp) to 90.7% (England 94.2%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,687

    Hypertension register

    +8.41%

    Register growth, 3 yrs

    Cheshire West and Chester (LAD) +6.60% · England +5.60%

    −5.19pp

    BP control, under 80

    ≤140/90 · −2.64pp aged 80+

    +1,726

    More patients by 2030

    Forecast 9,413 (21.47%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 18.3% (7,687 patients), above Cheshire West and Chester (17.0%), the ICB (16.8%) and England (15.2%). Although 89.8% of hypertensive patients had a recent blood pressure check, this reading rate fell 2.1% from 2023 to 2025 (England +3.6%). Blood pressure control among under-80s is 67.5%, trailing England (67.8%) after falling 7.1% from 2023 to 2025 (England +3.2%); overall treatment to threshold also fell 6.1% (England +3.6%). Denominators include personalised care adjustments.

    Lipids and statins

    For patients with QRISK ≥ 20%, 62.2% receive lipid-lowering therapy, below Cheshire West and Chester (63.8%) and England (63.6%), despite a 6.8% increase from 2023 to 2025 (England +6.2%). Meanwhile, CKD lipid therapy reaches 73.0% (England 70.3%).

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202694,646£1.30£1.71£1.86£123,040
    Cardiovascular (all), 2025125,790£5.31£4.37£3.33£667,945

    In 2026, the PCN prescribed 94,646 lipid-regulating items at £1.30 per item, below Cheshire West and Chester (£1.44), the ICB (£1.71) and England (£1.86), spending £53,002 less than at England's unit cost across 94,646 items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.21%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −0.19%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews fell 5.2% from 2023 to 2025 (England +4.4%) to 66.0% (England 65.7%), leaving about 960 of 2,811 register patients without an annual review. For patients aged 6–19 with asthma, second-hand smoke recording is 69.9%, trailing England (78.8%) and Cheshire West and Chester (75.2%). Meanwhile, COPD reviews reached 79.0% (England 76.4%), with 670 patients on the register (1.6% prevalence versus 1.9% in England).

    Cancer register and children's immunisation

    Cancer prevalence is 6.3% (2,638 patients), above England (3.8%), consistent with an older demographic (28.7% aged 65+). Childhood immunisation exceeds national rates: MMR dose 2 reaches 94.0% (England 82.8%) and 6-in-1 at 12 months reaches 92.2% (England 91.0%). However, 6-in-1 coverage is 2.8 pp below the 95.0% target.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.2%

    England 91.0%

    6-in-1 complete primary course at 24 months96.7%

    England 92.2%

    MMR dose 1 at 24 months96.7%

    England 88.3%

    MMR dose 2 at age 594.0%

    England 82.8%

    4-in-1 pre-school booster at age 594.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of staged cancers were diagnosed at stage 1 or 2 (7,482 of 13,490), in line with England (55.3%) but below the 75.0% national ambition by 2028 by 19.5 pp. Reaching that ambition requires about 2,640 extra early-stage cases annually across the ICB. Known-stage share was 72.8%. RURAL ALLIANCE PCN has a cancer prevalence of 6.3% (2,638 patients), growing +12.0% over three years (England +9.0%). ICB stage data describes the wider system, not PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026, Countess of Chester Hospital NHS Foundation Trust achieved 87.4% on the 28-day faster diagnosis standard, exceeding the 75.0% standard, the ICB (77.2%) and England (79.3%). For 31-day combined treatment, it achieved 93.5% against the 96.0% standard (ICB 95.7%, England 92.5%). Its 62-day standard was 83.3%, below the 85.0% standard by 1.7 pp, but above the ICB (76.2%), England (71.2%) and Mid Cheshire Hospitals NHS Foundation Trust (71.1%), while North Cheshire and Mersey NHS Foundation Trust reached 83.7%. Diagnostic 6+ week waits were 11.3% for MRI and 4.2% for CT, outperforming England (21.4% and 9.9%).

    Pathways within standard (%)Countess of ChesterMid CheshireNorth Cheshire and MerseyCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)87.3779.9580.2177.2579.32
    31-day treatment (96%)93.4886.2198.1795.7192.50
    62-day referral to treatment (85%)83.2871.1283.6776.2371.16
    Diagnostic waits over 6 weeks (%)Countess of ChesterMid CheshireNorth Cheshire and MerseyEngland
    MRI11.265.150.5321.40
    CT4.181.092.329.92
    Echocardiography31.445.5128.0428.48
    Colonoscopy26.4430.3415.9830.83
    Gastroscopy27.5231.8920.2429.02
    All 15 DM01 tests20.1612.726.3423.14
    Community services activityCheshire West and Chester residentsCheshire and Merseyside ICB
    Care contacts47,655541,280
    Referrals10,32597,150
    Patients with a contact18,585146,240

    Community services (residents of Cheshire West and Chester), Jun 2026 (provisional). In the provisional Jun 2026 Community Services Dataset, adults aged 65 and over accounted for 52.7% of all community contacts for Cheshire West and Chester residents (25,095 of 47,655 contacts). Community service activity is captured at local-authority level rather than by individual PCN, indicating substantial older-age community caseload across the surrounding borough.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Drs Adey And Dancy1150.099.4%78.9%99.4%
    Laurel Bank1110.092.4%81.2%97.7%
    Tarporley1080.068.1%75.6%93.2%
    Bunbury Medical1070.087.8%67.9%91.6%
    Kelsall1190.075.5%84.5%88.9%
    Village Surgeries1180.052.7%81.1%76.4%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNCheshire West and Chester (LAD)AssetPCNCheshire West and Chester (LAD)
    Care homes (catchment)8 (316 beds)n/aSchools (catchment)65n/a
    Children's centresno data15Places of worship90231
    Libraries216Food banks (VCS)n/a1
    Homelessness support (VCS)n/a1Day centres (VCS)11
    Carers support groups (VCS)11Primary schools (LA maintained)1770
    Primary academies1146Special schools15

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension control and lipid recall

    Under-80 BP control is 67.5% (England 67.8%), falling 7.1% from 2023 to 2025 (England +3.2%); QRISK ≥ 20% lipid therapy is 62.2% (England 63.6%). For discussion: run a pharmacist-led recall and titration review across practices for under-80 hypertensive patients above target and high-QRISK patients not on statins. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured asthma review and smoke recording

    Asthma reviews fell 5.2% (England +4.4%) to 66.0%, leaving about 960 of 2,811 patients unreviewed; age 6-19 second-hand smoke recording is 69.9% (England 78.8%). For discussion: introduce a single asthma review template prompting second-hand smoke recording, paired with after-school review slots. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    COPD case-finding and smoking support

    COPD prevalence is 1.6% (670 patients) versus 1.9% in England and 2.1% in Cheshire West and Chester, an unadjusted gap of +134 to +241 patients. For discussion: audit records for smokers and ex-smokers with repeat respiratory prescribing lacking a COPD code, and embed smoking cessation prompts. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Alternative health equity assessment (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Smoking cessation offer audit (p4)Smoking cessation support and treatment offered to patients with certain conditions (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Childhood immunisation recall review (p6)Cancer register · Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Cancer referral and safety netting (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Hypertension control and lipid recall (p12)Hypertension register · Hypertension: QOF prevalence · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Structured asthma review and smoke recording (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · COPD case-finding and smoking support (p12)COPD register · COPD: QOF prevalence · Aged 65+Core20PLUS5 approach · Tobacco and Vapes BillPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15